Send us Feedback

GenVec (GNVC)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

GNVC » Topics » ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

These excerpts taken from the GNVC 10-K filed Mar 16, 2009.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The information required by this item, with the exception of information relating to compensation plans under which equity securities of the Registrant are authorized for issue, which appears below, is incorporated by reference from our Proxy Statement relating to the 2009 Annual Meeting of Stockholders to be filed pursuant to General Instruction G(3) to Form 10-K.

Equity Compensation Plan Information

The following table discloses certain information about the options issued and available for issuance under all outstanding Company option plans as of December 31, 2008:

     
Plan Category   (a)
Number of Securities
to Be Issued upon
Exercise of
Outstanding Options, Warrants and Rights		   (b)
Weighted-Average Exercise Price of
Outstanding Options,
Warrants and Rights		   (c)
Number of Securities
Remaining Available for
Future Issuance
Under Equity
Compensation Plans
(Excluding Securities
Reflected in Column (a))
Equity compensation plans approved by security holders     9,831,243     $ 2.24       4,973,593  
Equity compensation plans not approved by security holders     —       —       —  
Total     9,831,243     $ 2.24       4,973,593  

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The information required by this item, with the exception of information relating to compensation plans under which equity securities of the Registrant are authorized for issue, which appears below, is incorporated by reference from our Proxy Statement relating to the 2009 Annual Meeting of Stockholders to be filed pursuant to General Instruction G(3) to Form 10-K.

Equity Compensation Plan Information

The following table discloses certain information about the options issued and available for issuance under all outstanding Company option plans as of December 31, 2008:

     
Plan Category   (a)
Number of Securities
to Be Issued upon
Exercise of
Outstanding Options, Warrants and Rights		   (b)
Weighted-Average Exercise Price of
Outstanding Options,
Warrants and Rights		   (c)
Number of Securities
Remaining Available for
Future Issuance
Under Equity
Compensation Plans
(Excluding Securities
Reflected in Column (a))
Equity compensation plans approved by security holders     9,831,243     $ 2.24       4,973,593  
Equity compensation plans not approved by security holders     —       —       —  
Total     9,831,243     $ 2.24       4,973,593  

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS





The information required by this item, with the exception of information relating to compensation plans under which equity securities of the Registrant are authorized for issue, which appears below, is incorporated by reference from our Proxy Statement relating to the 2009 Annual Meeting of Stockholders to be filed pursuant to General Instruction G(3) to Form 10-K.



Equity Compensation Plan Information



The following table discloses certain information about the options issued and available for issuance under all outstanding Company option plans as of December 31, 2008:





































































































































     
Plan Category   (a)
Number of Securities
to Be Issued upon
Exercise of
Outstanding Options, Warrants and Rights		   (b)
Weighted-Average Exercise Price of
Outstanding Options,
Warrants and Rights		   (c)
Number of Securities
Remaining Available for
Future Issuance
Under Equity
Compensation Plans
(Excluding Securities
Reflected in Column (a))
Equity compensation plans approved by security holders     9,831,243     $ 2.24       4,973,593  
Equity compensation plans not approved by security holders     —       —       —  
Total     9,831,243     $ 2.24       4,973,593  


ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS





The information required by this item, with the exception of information relating to compensation plans under which equity securities of the Registrant are authorized for issue, which appears below, is incorporated by reference from our Proxy Statement relating to the 2009 Annual Meeting of Stockholders to be filed pursuant to General Instruction G(3) to Form 10-K.



Equity Compensation Plan Information



The following table discloses certain information about the options issued and available for issuance under all outstanding Company option plans as of December 31, 2008:





































































































































     
Plan Category   (a)
Number of Securities
to Be Issued upon
Exercise of
Outstanding Options, Warrants and Rights		   (b)
Weighted-Average Exercise Price of
Outstanding Options,
Warrants and Rights		   (c)
Number of Securities
Remaining Available for
Future Issuance
Under Equity
Compensation Plans
(Excluding Securities
Reflected in Column (a))
Equity compensation plans approved by security holders     9,831,243     $ 2.24       4,973,593  
Equity compensation plans not approved by security holders     —       —       —  
Total     9,831,243     $ 2.24       4,973,593  


ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS





The information required by this item, with the exception of information relating to compensation plans under which equity securities of the Registrant are authorized for issue, which appears below, is incorporated by reference from our Proxy Statement relating to the 2009 Annual Meeting of Stockholders to be filed pursuant to General Instruction G(3) to Form 10-K.



Equity Compensation Plan Information



The following table discloses certain information about the options issued and available for issuance under all outstanding Company option plans as of December 31, 2008:





































































































































     
Plan Category   (a)
Number of Securities
to Be Issued upon
Exercise of
Outstanding Options, Warrants and Rights		   (b)
Weighted-Average Exercise Price of
Outstanding Options,
Warrants and Rights		   (c)
Number of Securities
Remaining Available for
Future Issuance
Under Equity
Compensation Plans
(Excluding Securities
Reflected in Column (a))
Equity compensation plans approved by security holders     9,831,243     $ 2.24       4,973,593  
Equity compensation plans not approved by security holders     —       —       —  
Total     9,831,243     $ 2.24       4,973,593  


EXCERPTS ON THIS PAGE:

10-K (5 sections)
Mar 16, 2009

RELATED TOPICS for GNVC:

"ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS" elsewhere:

ACADIA Pharmaceuticals (ACAD)
Affymax (AFFY)
Corcept Therapeutics (CORT)
EPIX Pharmaceuticals (EPIX)
EXACT Sciences (EXAS)
GTC Biotherapeutics (GTCB)
IGI (IG)
Metabasis Therapeutics (MBRX)
Memory Pharmaceuticals (MEMY)
Micromet (MITI)
Biota Pharmaceuticals, Inc. (NABI)
Neurobiological Technologies (NTII)
Osiris Therapeutics (OSIR)
Pharmacopeia Drug Discovery (PCOP)
Peregrine Pharmaceuticals (PPHM)
Sangamo BioSciences (SGMO)
Sunesis Pharmaceuticals (SNSS)
Savient Pharmaceuticals (SVNT)
Theravance (THRX)
SYNAGEVA BIOPHARMA CORP (TRMS)
Vical (VICL)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki